Professional Matters Ophthalmology News, October to December 2017
Ophthalmologists have expressed concern about the current shortages of essential eye drops and other drugs.
The Royal College of Ophthalmologists has advised members that while manufacturers have a legal duty to ensure continuity of supply of medicines to UK patients, shortages have occurred for various reasons relating to pressures on resources and fluctuations in supply and demand.
The Royal College intends to provide regular bulletins updating their members about known current and potential product shortages/discontinuation.
Hope in sight for UK’s 600,000 AMD sufferers.
New research reveals dietary supplements can lead to vision improvement for sufferers of the most common cause of sight loss
Results from a two-year eye health study - the first of its kind in the world – have shown a new hope for people suffering from age-related macular degeneration (AMD), the most common cause of sight loss in the UK.
The ground-breaking European Research Council-funded programme, involved over 100 people diagnosed with the early stages of dry AMD and revealed a major improvement in the vision of 40% of trial participants taking a dietary supplement of carotenoids.
Click here to our clinical briefing area on PHN to read about the nutritional study.
FODO welcome updated NICE glaucoma guideline supporting greater role for optometrists.
Updated guidance published today by the National Institute for Health and Care Excellence (NICE), ‘Glaucoma diagnosis and management’, clarifies the role optometrists can play in the diagnosis and management of glaucoma patients. The updated guidance NG81 can be read and downloaded here.
Welcoming the new guidance, FODO Chief Executive, David Hewlett, said: “This updated guideline is extremely helpful. The updated Intraocular Pressure (IOP) recommendation brings England and Wales more into line with Scotland and the pathway diagrams are extremely clear. Most importantly, the guideline should enable the NHS to plan services across primary and secondary care to make better use of all available capacity.”
FODO Clinical Adviser, Professor Steve Taylor, added: “Optometrists will welcome this new guidance, which makes clear their clinical role in the diagnosis and management pathway for Chronic Open Angle Glaucoma (COAG) and Ocular Hypertension (OHT). It allows for the greater use of their core competences in managing patients outside hospital, and sets a more rational IOP referral threshold. I hope the guidance will now lead to universal implementation of NHS funded glaucoma referral and care services.”
This is an update of the 2009 guideline on Glaucoma – ‘Glaucoma: diagnosis and management COAG and OHT’. It sets a new, higher IOP threshold for referral - bringing England more into line with Scotland - and establishes a blueprint for universal referral refinement services based on community optical practices. It also includes new information on: guideline committee and scope; methodology; case finding, diagnosis and monitoring; service models; prognostic risk tools; and the treatment of OHT.